Please wait while the formulary information is being retrieved.
CALYPXO (methyl salicylate/menthol)
10 %-3 % topical cream
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Burns
Severe
Moderate
- None
CALYPXO (methyl salicylate/menthol)
- None
- Stinging of skin
More Frequent
Severe
Less Severe
- None
- Dry skin
- Skin irritation
- Stinging of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Burns
- Dyspnea
- Facial edema
- Hypersensitivity drug reaction
- Periorbital edema
- Pharyngeal edema
- Skin ulcer
- Superficial skin ulcer
- Syncope
- Throat constriction
- Urticaria
Less Severe
- Pruritus of skin
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Salicylates (Topical)
Prolonged use or use on extensive skin areas may lead to systemic toxicity, e.g. hemostatic or metabolic changes.
- 1 Day – 13 Years
- Prolonged use or use on extensive skin areas may lead to systemic toxicity, e.g. hemostatic or metabolic changes.
Methyl Salicylate (topical)
- Severity Level:
2
- Additional Notes: Small amount of drug absorbed systemically; not recomm in preg
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Methyl Salicylate (topical/nasal)
Small amt of drug absorbed systemically;Risk of reye's syn w/oral salicylates
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Small amt of drug absorbed systemically;Risk of reye's syn w/oral salicylates |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool